Cipla Limited (CIPLA.BO)

INR 1490.75

(1.27%)

Operating Expenses Summary of Cipla Limited

  • Cipla Limited's latest annual operating expenses in 2023 was 59.21 Billion INR , down -33.08% from previous year.
  • Cipla Limited's latest quarterly operating expenses in 2024 Q1 was 15.91 Billion INR , down -7.12% from previous quarter.
  • Cipla Limited reported a annual operating expenses of 94.94 Billion INR in annual operating expenses 2022, up 7.61% from previous year.
  • Cipla Limited reported a annual operating expenses of 88.23 Billion INR in annual operating expenses 2021, up 14.33% from previous year.
  • Cipla Limited reported a quarterly operating expenses of 30.64 Billion INR for 2024 Q2, up 5.25% from previous quarter.
  • Cipla Limited reported a quarterly operating expenses of 27.77 Billion INR for 2023 Q1, up 45.92% from previous quarter.

Annual Operating Expenses Chart of Cipla Limited (2023 - 2003)

Historical Annual Operating Expenses of Cipla Limited (2023 - 2003)

Year Operating Expenses Operating Expenses Growth
2023 59.21 Billion INR -33.08%
2022 94.94 Billion INR 7.61%
2021 88.23 Billion INR 14.33%
2020 77.17 Billion INR -3.23%
2019 79.74 Billion INR 5.28%
2018 75.74 Billion INR 12.25%
2017 67.47 Billion INR 3.65%
2016 65.1 Billion INR 9.03%
2015 59.7 Billion INR 18.99%
2014 50.18 Billion INR 28.36%
2013 39.09 Billion INR 24.33%
2012 31.44 Billion INR 25.77%
2011 25 Billion INR 24.35%
2010 20.1 Billion INR 21.67%
2009 16.52 Billion INR 13.12%
2008 14.6 Billion INR 58.11%
2007 9.23 Billion INR 26.23%
2006 7.31 Billion INR 21.91%
2005 6 Billion INR 38.34%
2004 4.34 Billion INR 32.11%
2003 3.28 Billion INR 0.0%

Peer Operating Expenses Comparison of Cipla Limited

Name Operating Expenses Operating Expenses Difference
Abbott India Limited 5.98 Billion INR -889.237%
Gland Pharma Limited 3.86 Billion INR -1433.498%
GlaxoSmithKline Pharmaceuticals Limited 4.35 Billion INR -1259.028%
Kopran Limited 859.54 Million INR -6789.392%
Marksans Pharma Limited 3.28 Billion INR -1700.237%
NGL Fine-Chem Limited 816.16 Million INR -7155.613%
Pfizer Limited 4.33 Billion INR -1265.344%
Sanofi India Limited 3.69 Billion INR -1503.512%
SMS Pharmaceuticals Limited 370.89 Million INR -15866.249%